These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18727708)

  • 1. Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
    Camacho CP; Latini FR; Oler G; Hojaij FC; Maciel RM; Riggins GJ; Cerutti JM
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):475-83. PubMed ID: 18727708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signatures of thyroid follicular neoplasia.
    Borup R; Rossing M; Henao R; Yamamoto Y; Krogdahl A; Godballe C; Winther O; Kiss K; Christensen L; Høgdall E; Bennedbaek F; Nielsen FC
    Endocr Relat Cancer; 2010 Sep; 17(3):691-708. PubMed ID: 20668010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
    Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
    Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
    Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
    Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
    Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
    Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
    J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
    Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
    Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
    J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
    Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
    Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ARE-binding proteins AUF1 and HuR in follicular adenoma and carcinoma of thyroid gland.
    Trojanowicz B; Sekulla C; Dralle H; Hoang-Vu C
    Neoplasma; 2016; 63(3):371-7. PubMed ID: 26925783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
    Wojtas B; Ferraz C; Stokowy T; Hauptmann S; Lange D; Dralle H; Musholt T; Jarzab B; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2014 May; 388(1-2):1-9. PubMed ID: 24631480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.